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Abstract
Background: Mastitis is the most important disease in dairy cows and it causes significant lost of
profit to producers. Identification of the genes, and their variants, involved in innate immune
responses is essential for the understanding of this inflammatory disease and to identify potential
genetic markers for resistance to mastitis. The progeny of dairy cows would benefit from receiving
favourable alleles that support greater resistance to infection, thus reducing antibiotic use. This
study aims to identify a key gene in the innate immune response to mastitis, led us to evaluate its
genetic association with somatic cell score (SCS), which is an indicator of clinical mastitis, and to
evaluate its impact on other traits related to milk production.
Results:  The osteopontin transcript (SPP1) was identified in the somatic cells from cows
experimentally infected with Escherichia coli. By selecting bulls with extreme estimated breeding
values (EBVs) for SCS, which is an indicator of mammary gland health, four DNA polymorphisms
in the SPP1  genomic sequence were found. Statistical analysis revealed that the SNP SPP1c.-
1301G>A has an impact on EBV for SCS (P < 0.001) Using an allele substitution model, SPP1c.-
1251C>T, SPP1c.-430G>A, and SPP1c.*40A>C have an impact on SCS whereas SPP1c.-1301G>A has
an effect on the EBVs for milk yield (second and third lactations), fat and protein percentages (all
three lactations). Analysis revealed statistically significant differences between haplotype groups at
a comparison-wise level with sire EBVS for SCS for the first (P = 0.012), second (P < 0.001), and
third (P < 0.001) lactations.
Conclusion: This study reports the link between DNA polymorphisms of SPP1, the number of
milk immune cells and, potentially, the susceptibility to mastitis. These SNPs were identified by in
silico search to be located in transcription factor recognition sites which factors are presumably
involved in the Th1 immune response and in the Th2 regulation pathway. Indeed, one SNP
abolished the SP1 recognition site, whereas another SNP affected the transcription binding factor
IKAROS. All together, these findings support the genetic potential of these variants in terms of
selection for the improvement of mastitis resistance in dairy cows.
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Background
Mastitis is an inflammatory condition of the mammary
gland caused primarily by microorganisms, usually bacte-
ria, that invade the udder, multiply and secrete toxic prod-
ucts that are very harmful to the host. In Canada,
environmental mastitis (clinical mastitis) is most com-
monly caused by Escherichia coli. This infection is gener-
ally short taking a few days to be eliminated by the
immune system, but the animal presents severe clinical
signs that include inflammation of the udder, milk clots
and altered behaviour (fever, loss of appetite). With
annual costs for the herd of approximately $180 per cow
[1], mastitis is still the most commonly occurring disease
in Canadian dairy herds. These important losses to pro-
ducers result not only from early culling and treatment
costs, but also from the adverse effects of the decrease in
production, and the need to discard milk that is unfit for
human consumption because it is infected or contains
antibiotic residues [2,3].
The mammary gland is typically a sterile environment
and, therefore, the entry of any foreign body usually trig-
gers a localized immune response. The first line of defence
against disease-causing microorganisms is the innate
immune system, which induces mechanisms that are not
pathogen species-specific [4]. Innate immune cells in the
mammary gland are comprised of macrophages, granulo-
cytes, natural killer cells, and dendritic and mammary epi-
thelial cells [5]. These cells have receptors that recognize
motifs or pathogen-associated molecular patterns
(PAMP) on the surface of microorganisms. For example,
the lipopolysaccharides on the surface of Gram-negative
bacteria such as E. coli become attached to the phagocytic
cells via Toll-like receptor 4 (TLR-4), whereas Toll-like
receptor 2 (TLR-2) binds to Gram-positive motifs such as
peptidoglycan or lipoteichoic acid on the surface of S.
aureus [6].
Recognition of an invading pathogen activates cellular
reactions, leading to the secretion of inflammatory medi-
ators called cytokines. These signalling molecules trigger
cellular communication, chemotaxis and lymphocyte dif-
ferentiation. The cytokines include inflammatory inter-
leukins-(IL)-1β, -6 and -12, tumour necrosis factor-alpha
(TNF-α) and interferon-gamma (IFN-γ) [7]. Once phago-
cytic cells recognize and internalize pathogens, the cells
present the pathogen's antigenic determinants to the T
lymphocytes. Then these cells, in the presence of IL-12,
differentiate into Th1 effector cells which are responsible
for cell-mediated immunity. These Th1 cells produce
inflammatory mediators such as IFN-γ, that enhance mac-
rophage effectors functions against intracellular patho-
gens [8].
Macrophages are the predominant cells in the healthy
mammary gland [9]. During intramammary infection,
however, a release of inflammatory mediators, especially
by macrophages, leads to the recruitment of neutrophils
into infected quarters from the circulation. At this stage,
these cells account for more than 90% of milk cells [10].
The neutrophils are responsible for the eventual elimina-
tion of the pathogens. For example, activated neutrophils
degranulate and produce/secrete bactericidal compo-
nents, namely reactive oxygen species (ROS) [11]. The
recruitment of neutrophils into the mammary gland
causes an increase in somatic cell count (SCC) that can
reach more than 1,000,000 cells/mL during the course of
an infection, whereas the SCC is normally less than
100,000 cells/mL in a healthy mammary gland [4].
Prevention and control of mastitis by improving the nat-
ural defence mechanisms is important not only for dairy
producers but also for consumers, because of increased
concerns about food safety, antibiotic use and animal wel-
fare [12]. One approach would be to define breeding
objectives with increased weight of health-related traits in
genetic selection [13]. Genetic selection to increase anti-
body responsiveness seems to be possible, but the
acquired immune response traits have proven to be incon-
sistent indicators of udder health [14]. Components of
the adaptive immune system have been studied inten-
sively, but there is still need for the development of effi-
cient vaccine against pathogens that cause intramammary
infection for bovine [12,15-17]. Unlike the adaptive
immune system, some mechanisms of the innate immu-
nity are conserved throughout the animal kingdom and
can thus be thought of as general mechanisms responsible
for broad environmental responses. These evolutionarily
conserved systems have been analyzed in detail and
include, among others, the complement gene family [18]
and the Toll-like receptors (TLR) [19]. The parameters of
innate immune responses can be used to study resistance
to mastitis. These results can lead to the selection of breed-
ing animals that carry favorable polymorphisms or alleles
able to improve the resistance to infection of their off-
spring. [20].
Genetic parameters such as heritability and phenotypic
and genetic correlations are useful statistical tools for
measuring the genetic component of a trait or group of
traits. These genetic parameters do not require any knowl-
edge about the number of genes involved as they are esti-
mated from correlations of phenotypic data among
relatives. The present study is based essentially on the
somatic cell score (SCS), because data for clinical mastitis
prevalence are still not available for the Canadian dairy
population [21]. However, the usefulness of SCS as an
indirect selection tool for reducing mastitis has been
reported in several studies [22-25]. Most estimates of the
genetic correlation between SCS and clinical mastitis
range from 0.50 to 0.80 [26-29]. In a recent study, the
genetic correlation was observed to ranges from 0.55 toBMC Genomics 2009, 10:444 http://www.biomedcentral.com/1471-2164/10/444
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0.93 [30]. These are reasonably high values which suggest
that SCC and mastitis occurrence are partly caused by the
expression of the same trait. The SCC distribution is often
highly skewed and it is usually transformed on a loga-
rithm scale, as follows: SCS = log2 (SCC/100,000) + 3
[22]. When used for genetic evaluation, bulls receive an
estimated breeding value (EBV) based on the SCS records
of their daughters. If dairy producers select bulls with a
low EBV for SCS, this is expected to improve mastitis
resistance in their herd [22,28,31]. The SCS has now
become the most important indicator associated with the
health of the mammary gland, but little is known about
the key factors which regulate the number of somatic cells
in milk from healthy cows. Thus, in the present study we
investigated the early activated transcripts of immune cells
of the lactating mammary gland in order to identify a key
gene in the innate immune response to mastitis.
Osteopontin (or secreted phosphoprotein 1, SPP1) is a
cytokine produced by macrophages and activated T cells
[32]. Osteopontin has been described as an early compo-
nent of the T cell activation mechanism. Enhanced in T
cells, it recruits macrophages at the infection site and
improves cell-mediated immunity (Th1) by inducing
secretion of Th1 cytokines [33-36]. Osteopontin is a
multi-faced protein [35,37]. It promotes bone remodel-
ling [38], wound healing and survival of stressed cells
[39], but is also associated with metastasis status and poor
survival prognosis [40,41]. It was found associated with
certain pathologies such as restenosis, formation of kid-
ney stones, and autoimmune disease [37], but also found
to confer resistance to several intracellular pathogen infec-
tions through recruitment and activation of macrophages
[42]. In this study, we reported the detection of this abun-
dant transcript, which is expressed early on during masti-
tis. Following the detection of this key gene in the
mammary somatic cells isolated early during the immune
response, we evaluated the association of SPP1 with SCC,
which is the most widely used indicator of mastitis [31].
Identifying favourable SPP1 alleles for mastitis resistance
would make it possible for dairy breeders to increase them
in the Canadian Holstein population to potentially
increase the natural resistance to mammary gland infec-
tion.
Results
Experimental mastitis and detection of the candidate gene
An infectious dose of 94 ± 8 CFU of a fresh exponential
culture of E. coli was used and produced a bacterial infec-
tion in all challenged quarters (Figure 1A) of the four lac-
tating cows: groups 6 h (n = 2) and 12 h (n = 2). The front
control quarters, which had been infused with saline,
remained free of bacteria. There were no apparent signs of
clinical infection at 6 h whereas infection was confirmed
by 12 h. These two cows showed signs of clinical infec-
tion: clotting in milk, fever (40°C), and local redness
along with pain after 12 h. The tumour necrosis factor-
alpha (TNF-α) was detectable in milk at 9 h post-infection
(Figure 1A). Increases in both SCC and granulocytes in
milk were highly correlated between 6 and 9 h post-chal-
lenge (Figure 1B), which confirmed that granulocytes
were the major invading cells in the mammary gland
upon infection. During the same 6-to-9-h period, macro-
phages drastically decreased in proportion (P < 0.05; Fig-
ure 1B). Only 2 to 4% remained detectable whereas in the
bacteria-free quarters, a significant level (51 to 56%) of
macrophages was maintained. The inflection point for
this longitudinal survey was 6 h. Indeed, no changes in
the distribution of lymphocytes, macrophages and granu-
locytes in milk, between infected quarters (continuous
lines) and uninfected quarters (dashed lines) were appar-
ent in the first 6 h post-infection (Figure 1B). We thus
monitored the molecular events prior to the increase of
granulocytes (inflection point) in milk. The differential
transcripts of milk immune cells were analysed at 5 h
post-infection. One hundred clones from the cDNA
library of milk immune cells were sequenced (Material
and Methods). The SPP1 transcript was identified using
the Basic Local Alignment Search Tool (BLAST) to search
against the National Center for Biotechnology Informa-
tion (NCBI) database. This induction of SPP1 transcript
was also observed in PBMC (peripheral blood mononu-
clear cells) challenged in vitro with heat-inactivated bacte-
ria as described in Material and Methods. The increased
SPP1 transcripts abundance in PBMC was detected within
6 h (up to 4 fold by 3 h) by real-time RT-PCR in three
independent assays (data not shown).
Analysis of the SPP1 genomic sequence
Search for DNA polymorphisms was performed by select-
ing bulls with extreme EBV for SCS (Material and Meth-
ods). Each different genomic region of SPP1 (promoter, 5'
untranslated sequence [UTR], intron 1, exons 1-7 and 3'
UTR) were sequenced as described in Materials and Meth-
ods. Comparison of the results of the electrophoregrams
from the two groups presenting extreme EBV for the SCS
trait uncovered differences in the allelic distribution of
four nucleotides. Two single-nucleotide polymorphisms
(SNPs) were found in the promoter. A novel SNP was
identified and has been submitted to NCBI dbSNP on
April 23rd 2009 (SNP submission number ss130452346).
This novel transition SNP (SPP1c.-1301G>A) and the tran-
sition SNP SPP1c.-1251C>T were found respectively 1,301
and 1,251 nucleotides (nt) before the ATG (start) codon,
which initiates translation from exon 2. The third transi-
tion SNP (SPP1c.-430G>A) was located in the first intron,
430 nt upstream from the start codon. Lastly, the transver-
sion SNP (SPP1c.*40A>C) was found 40 nt downstream
from the stop codon in exon 7 within the 3' UTR. No SNPs
were found in the coding region. We scrutinized the elec-BMC Genomics 2009, 10:444 http://www.biomedcentral.com/1471-2164/10/444
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trophoregrams in the 2,428-to-2,419-nucleotide region
upstream from the ATG gene corresponding to the inser-
tion and deletion (INDEL) variation rs43702359 (NCBI
dbSNP accession number) which had been reported else-
where [43]. No such variation was observed in the popu-
lation sequenced.
SNPs and allelic frequencies
Genotypic and allelic frequencies of the four SNPs for the
578 bulls are summarized in Table 1. All SNPs were
checked for conformance with the Hardy-Weinberg equi-
librium, as determined by the Chi-square test. The fre-
quency of the alleles varied in the population. Some
alleles were present in low frequency, such as allele A
(10.5%) for the SNP SPP1c.-1301G>A, which also
explained the low abundance of homozygous bulls
(1.0%) in the population tested. Homozygous bulls har-
bouring the genotype T for SPP1c.-1251C>T and genotype
A for SPP1c.-430G>A were not frequent (6.4%), and the
abundance of these alleles was 25.2% for both among the
578 genotyped bulls. These two SNPs were linked in the
population tested: allele C for SPP1c.-1251C>T was linked
to allele G for SPP1c.-430G>A, and vice versa (allele T
linked to allele A). For the SNP SPP1c.*40A>C, 9.1% of
the bulls were homozygous for allele C, a proportion of
30% in the population genotyped (Table 1).
SNP associations
The EBVs for SCS at the first, second and third lactations
and for over all lactations are reported according to the
genotypes for SPP1c.-1301G>A, SPP1c.-1251C>T, SPP1c.-
430G>A and SPP1c.*40A>C (Table 2). Allele G of SPP1c.-
1301G>A had a favourable impact on SCS EBV at any lac-
tation (P < 0.001). The SNP SPP1c.-1251C>T and SPP1c.-
430G>A did not have an effect on SCS EBV (global com-
parison - over all lactations), but genotypic comparison
showed a significant difference for the third lactation only
between homozygous and heterozygous bulls for the
dominant allele (P = 0.046; data not shown). The statisti-
cal analysis also revealed a stronger association between
SPP1c.*40A>C and EBVs for SCS as the number of lacta-
tions increased: first lactation (SCS1; P = 0.183), second
lactation (SCS2; P = 0.014) and third lactation (SCS3; P =
0.004).
The estimated average allele substitution effects are pre-
sented in Table 3. No significant association of SNP
SPP1c.-1301G>A was detected with SCS in any of the lac-
tations. The SNP SPP1c.-1251C>T  and  SPP1c.-430G>A
were significant at a comparison-wise level in association
with EBVs for SCS (P = 0.014), SCS1 (P = 0.035), and
SCS2 (P = 0.023). The estimated substitution effect was
about the same for SCS3 but the larger SE crushed the sta-
tistical validity (P = 0.056). The allele substitution effects
for SPP1c.-1251C>T for over all, first, and second lacta-
tions are respectively 0.117 ± 0.047, 0.097 ± 0.046 and
0.118 ± 0.052. Thus, the increase in SCS for allele T over
allele C corresponded to 33% of the SD for SCS EBV. The
same effects on EBV for SCS were found for SPP1c.-
430G>A, but the negative allelic substitution effect carried
by allele A had the opposite effect (reduced the EBV for
SCS). Although it was not significant for the first lactation
(SCS1; P = 0.121), the 3' UTR SNP SPP1c.*40A>C was
associated with EBVs for SCS2 (P = 0.038), SCS3 (P =
0.045) and over all lactations (P = 0.023); the correspond-
ing allele substitution effects for this SNP were -0.103 ±
0.049, -0.112 ± 0.056 and -0.102 ± 0.045, respectively,
meaning that allele C reduces SCS over allele A.
Effect of SPP1 SNPs for production traits
The average substitution effect of the SNP SPP1c.-
1301G>A was significant for milk yield from the second (P
= 0.027) and third (P = 0.046) lactations. Substitution of
Experimental mastitis Figure 1
Experimental mastitis. Milk samples were analysed at dif-
ferent times for intramammary bacterial infection (pannel A; 
CFU, left y-axis), inflammatory mediator (pannel A; TNF-α; 
right y-axis), and for somatic cell profil (pannel B). Data are 
expressed as mean ± standard error of the mean. During the 
first 6 hours post-challenge, mean values of 4 cows are 
reported. By 6 hours, two cows were not sampled because 
they received antibiotics (Materials and Methods). Error bars, 
standard error of the means.
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allele G over allele A decreased the EBV for milk yield by
the equivalent of 178 kg and 165 kg, respectively (Table
4). Although no significant effect was observed for fat or
protein yield (kg), the same allele G had a favourable
effect on the EBVs for the fat and protein percentages. Pro-
tein percentages were associated with the SNP in the sec-
ond (P = 0.030) and third (P = 0.036) lactations (0.03%
± 0.01), whereas the effects for fat percentages were
observed for all three lactations, as follows: 0.08% ± 0.03
(P = 0.004), 0.09% ± 0.03 (P = 0.012) and 0.08% ± 0.03
(P = 0.009), respectively. None of the three other SNPs
was found to have a significant allelic substitution effect
when associated with the EBVs for production traits (data
not shown) or any significant effect using the regression
model (Additional file 1). However, all three SNPs were
associated with EBVs for fat yield and fat percentage (P <
0.05) (Additional file 1).
Haplotype analysis
Table 5 shows the estimated population haplotype fre-
quencies, comparing two different algorithms provided
by the HAPROB and Haploview analysis methods. Both
methods reported that four haplotypes were more likely
to be present in the population tested. However, HAPROB
analysis was more sensitive for detecting low abundant
alleles. Block H1 (GCGA) was the most frequent haplo-
type (59.2%), whereas block H5 was detected in only six
offspring among the 578 bulls. Blocks H2, H3 and H4 had
frequencies equal to 0.24, 0.10 and 0.05, respectively. The
remaining haplotypes, H6 to H13, had frequencies less
than 0.2% and were pooled together (into H6) for statis-
tical analysis. Table 6 reports the genotypes of both alleles
from all 578 bulls, displayed using the haplotype blocks
present in the population (Table 5). The EBVs (least mean
squares) for all traits are reported, according to their
homozygosis or heterozygosis, sorted by increasing value
of the EBV for SCS for the over all lactations. Analysis
revealed statistically significant differences between hap-
lotype groups at a comparison-wise level with EBVs for
SCS1 (P = 0.012), SCS2 (P < 0.001), SCS3 (P < 0.001) and
over all lactations (P < 0.001). For production trait, anal-
ysis revealed statistically significant differences between
haplotype groups at a comparison-wise level with EBVs
for fat (P = 0.044) and fat percentage (P = 0.043) (Table
6), and for protein percentage for the first and second lac-
tations only (data not shown). None of the haplotypes
produced a significant allele substitution effect on EBV for
SCS or for the production traits (Table 7 or Additional
file 1).
Discussion
The objective of this work was to identify one candidate of
the innate immune response, to define the association of
the genetic variants with the immune cells in milk, but
also to evaluate their impact on other traits related to
dairy production. Osteopontin has been described as an
early component of the T cell activation mechanism and
was also detected in the immune cells in the present study
during the first hours of E. coli infection. This confirms the
results of other studies which show the importance of
osteopontin in inflammatory responses. The expression
of SPP1 is enhanced in T cells during bacterial infection in
order to recruit macrophages to the infection site and to
improve cell-mediated immunity (Th1) by increasing the
secretion of Th1 cytokines [34-36]. Indeed, knockout
SPP1-/-  mice have shown significantly impaired Th1
immunity to viral and bacterial infections with dimin-
ished production of interleukin-12 (IL-12) and inter-
feron-gamma (IFN-γ) and elevated production of
interleukin-10 (IL-10) [44]. However, no studies have
been carried out to correlate osteopontin with mastitis.
Innate immune responses are activated by a cross-species
conserved signalling pathway. Study of this activation
Table 1: Genotype and allele frequencies of the SNPs detected in the bovine SPP1 gene.
DNA polymorphisms Genotype Code Frequency (%) Allele Frequency (%)
SPP1c.-1301G>A GG -1 463 (80.1) G 1035 (89.5)
GA 0 109 (18.9)
AA 1 6 (1.0) A 121 (10.5)
SPP1c.-1251C>T CC -1 324 (56.1) C 865 (74.8)
CT 0 217 (37.5)
TT 1 37 (6.4) T 291 (25.2)
SPP1c.-430G>A GG -1 324 (56.1) G 865 (74.8)
GA 0 217 (37.5)
AA 1 37 (6.4) A 291 (25.2)
SPP1c.*40A>C AA -1 287 (49.6) A 813 (70.3)
AC 0 239 (41.4)
CC 1 52 (9.1) C 343 (29.7)BMC Genomics 2009, 10:444 http://www.biomedcentral.com/1471-2164/10/444
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could lead to the identification of candidates genes for
disease resistance. The detection of favourable allelic vari-
ants of the innate immune response genes will make it
possible to select progeny with a more efficient immune
system. Because of the potential immunological role of
SPP1 in the milk of cows diagnosed with mastitis, the next
step was the validation of SPP1  genetic variants that
would explain the SCS observed in the dairy population.
Indeed, although SCS in milk is an indirect measure of
cow health status, SCS is considered to be the most widely
used biological marker of clinical mastitis in lactating
cows [30]. We thus found polymorphisms in the genomic
sequence of SPP1 that influence the number of somatic
cells in milk and, potentially, influence their susceptibility
to mastitis, although this latter assumption remains to be
validated. Through the use of animals with extreme EBV
for SCS, a novel SNP was discovered in the promoter
region of SPP1  (SPP1c.-1301G>A), 50 nucleotides (nt)
upstream from the SNP SPP1c.-1251C>T.
The 5' UTR SNP SPP1c.-1251C>T and SPP1c.-430G>A, and
the 3' UTR SNP SPP1c.*40A>C were also identified both
in the present study and in a previous one [43]. These
DNA polymorphisms were not investigated for an associ-
ation with SCS. However, these authors found one DNA
polymorphism (T9/T10 INDEL) that had an effect on the
fat and protein percentage traits, based on the results of
167 bull sires, but was not associated with SCS [43]. This
INDEL polymorphism, which corresponds to polyT tract
alleles of either nine or 10 thymines (T9/T10 INDEL), is
absent from the 100 bulls sequenced in the present study,
and also from the mouse [45], human and swine SPP1
promoter (see sequence alignment in Additional file 2A).
The bovine SPP1 region containing this polymorphism
Table 2: Effects of polymorphisms in the bovine SPP1 gene on EBVs for SCS for the first, second, third, and over all lactations.
SNP Least squares meana (± SEM)a P value
SPP1c.-1301G>A GG GA AA
SCS 2.98b 3.16c 3.38c (± 0.14) <.001
SCS1 2.98b 3.10c 3.25b, c (± 0.13) <.001
SCS2 2.96b 3.14c 3.39c (± 0.15) <.001
SCS3 2.99b 3.16c 3.50c (± 0.16) <.001
SPP1c.-1251C>T CC CT TT
SCS 3.04 2.97 3.02 (± 0.06) 0.067
SCS1 3.02 2.98 3.02 (± 0.05) 0.446
SCS2 3.03 2.96 3.00 (± 0.06) 0.155
SCS3 3.06b 2.97c 3.01b, c (± 0.07) 0.057
SPP1c.-430G>A GG GA AA
SCS 3.04 2.97 3.02 (± 0.06) 0.067
SCS1 3.02 2.98 3.02 (± 0.05) 0.446
SCS2 3.03 2.96 3.00 (± 0.06) 0.155
SCS3 3.06b 2.97c 3.01b, c (± 0.07) 0.057
SPP1c.*40A>C AA AC CC
SCS 3.06b 2.97c 2.98b, c (± 0.05) 0.004
SCS1 3.03 2.98 2.98 (± 0.05) 0.183
SCS2 3.05b 2.95c 2.97b, c (± 0.05) 0.014
SCS3 3.09b 2.97c 2.97b, c (± 0.06) 0.004
a The least square means are the adjusted means of the EBVs for the SCS for bulls which are grouped by genotype for each SNP and calculated for 
the respective lactation (over all, first, second or third lactations). SEM standard error of the mean.
b, c Means (within a line) without a common superscript letter differ from each other at the 5% level of significance.
Table 3: Association of the SNPs in the SPP1 gene with EBVs for SCS.
Average allelic substitution effect (in EBV units of score)a
SCS SCS1 SCS2 SCS3
DNA Polymorphisms Average allele effect ± SE (P value)
SPP1c.-1301G>A 0.047 ± 0.030 (0.121) 0.033 ± 0.030 (0.280) 0.047 ± 0.034 (0.165) 0.035 ± 0.038 (0.362)
SPP1c.-1251C>T 0.117 ± 0.047 (0.014) 0.097 ± 0.046 (0.035) 0.118 ± 0.052 (0.023) 0.112 ± 0.059 (0.056)
SPP1c.-430G>A - 0.117 ± 0.047 (0.014) - 0.097 ± 0.046 (0.035) - 0.118 ± 0.052 (0.023) - 0.112 ± 0.059 (0.056)
SPP1c.*40A>C - 0.102 ± 0.045 (0.023) - 0.068 ± 0.044 (0.121) - 0.103 ± 0.049 (0.038) - 0.112 ± 0.056 (0.045)
a EBVs are calculated for the respective lactation: over all (SCS), first (SCS1), second (SCS2), and third (SCS3) lactationsBMC Genomics 2009, 10:444 http://www.biomedcentral.com/1471-2164/10/444
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(also -1,301 and -1,251 nt) was aligned with other mam-
mals using the CLUSTALW algorithm (Additional file 2A).
This region does not contain any transcription factor (TF)
motifs (data not shown). The T9/T10 INDEL polymor-
phism may not associate with TF. It is located 1,119 nt
upstream from the novel SPP1c.-1301G>A, is absent from
sequenced individuals selected, and thus may not be a
functional SNP for the SCS trait. Therefore, we cannot
exclude this T9/T10 INDEL polymorphism from the Cana-
dian population, since the present experimental design
does not address differences among bulls with extreme
EBVs based on production traits (e.g. fat).
We searched for cross-species similarity in regions of the
genome containing the SNP detected in the present study.
Both of the SNPs in the promoter are very similar to other
species (Additional file 2: B and C). Interestingly, these
regions included a "GC-rich" area identical to both the
mouse and the human regions. Among the potential func-
tional factors that could explain the impact on the EBV for
the SCS, IKZF2 (IKAROS family zinc finger 2) and SP1 are
two TFs that recognize binding sites at or in the vicinity of
the SNP (Figure 2). The TF SP1 binds specifically to GC
box DNA within the 5' flanking promoter sequences for
promoting eukaryotic transcription [46,47]. Specifically,
the TF SP1 binds to the SPP1 promoter and is involved in
Th1 immune responses [48]. The TF IKZF2 is a regulator
of Th2 responses [49]. In that way, allele G of SPP1c.-
1301G>A abolishes IKZF2 recognition (Figure 2). Thus,
impaired IKZF2 binding would have the consequence of
promoting a Th1 immune response in the absence of a
Th2 polarizing effect on naive immune cells [49].
Impaired IKZF2 binding could also facilitate the access of
SP1 (Th1 response) through its binding activity, which is
present in the vicinity of SPP1c.-1301G>A (Figure 2). This
hypothesis is supported by the fact that allele A is associ-
ated with an elevated SCS (Table 3), SCS having been
associated with increased mastitis incidence [30]. Indeed,
an inefficient Th1 response or abrogated innate immunity
predisposes cows to environmental mastitis.
Table 4: Association of the SNP SPP1c.-1301G>A in the SPP1 gene with EBVs for production traits.
EBV unit
over all lactations 1st lactation 2 nd lactation 3 rd lactation
Trait Average allele effect ± SE (p value)
Milk yield (Kg) -116 ± 78 (0.142) -177 ± 91 (0.052) -178 ± 80 (0.027) -164 ± 82 (0.046)
Fat yield (Kg) 2 ± 3 (0.500) 3 ± 3 (0.289) 1 ± 3 (0.658) 2 ± 3 (0.485)
Protein yield (Kg) -2 ± 2 (0.420) -3 ± 3 (0.175) -3 ± 2 (0.167) -3 ± 2 (0.251)
Fat % 0.05 ± 0.03 (0.059) 0.09 ± 0.03 (0.004) 0.08 ± 0.03 (0.012) 0.08 ± 0.03 (0.009)
Protein % 0.02 ± 0.01 (0.090) 0.02 ± 0.01 (0.060) 0.03 ± 0.01 (0.030) 0.03 ± 0.01 (0.036)
Table 5: Estimated haplotype block and population frequencies of the SPP1 locus.
Haplotype SPP1c.-1301G>A SPP1c.-1251C>T SPP1c.-430G>A SPP1c.*40A>C Frequencya Frequencyb
H1 G C G A 0.59230 0.599
H2 G T A C 0.23976 0.252
H3 A C G A 0.10267 0.105
H4 G C G C 0.05079 0.045
H5 G T A A 0.00704
H6 A T A C 0.00164
H7 G T G C 0.00125
H8 G C A C 0.00123
H9 A C G C 0.00107
H10 G C A A 0.00106
H11 G T G A 0.00104
H12 A C A C 0.00003
H13 A T G A 0.00003
H14 A T G C 0.00003
H15 A C A A 0.00003
H16 A T A A 0.00003
aAnalysis were performed using HAPROB [72]
bAnalysis were performed using Haploview [73], version 4BMC Genomics 2009, 10:444 http://www.biomedcentral.com/1471-2164/10/444
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An additional SP1 recognition site was found in the loca-
tion of SPP1c.-1251C>T, with allele T abolishing the SP1
GC box recognition (Figure 2). This TF binding site has
been found to colocalize with the human "-66T" SNP,
which is referred to as the human SPP1 transcription start-
ing site [48]. The authors, Hummelshoj et coll., confirmed
by electrophoretic mobility shift assay that recognition of
the TF SP1 is influenced by the presence of DNA polymor-
phism. Furthermore, using a luciferase assay reporting the
SPP1  promoter, they observed increased activity with
allele T compared to allele C for the corresponding -66 T/
G SNP [48]. Alignment of human and bovine sequences
revealed that the -66 T/G SNP is located 7 nt from the
bovine SNP SPP1c.-1251C>T, both within the TF SP1
binding site. Although it remains to be confirmed, the
influence of the SNP SPP1c.-1251C>T on the regulation of
the bovine promoter is highly plausible. Indeed, the regu-
lation of promoters based around the Sp family binding
protein has been observed in a number of housekeeping
genes. These factors act as transcriptional activators in
mammalian cells [50]. Since SP1 recruits the basal tran-
scription machinery and controls the rate of transcription
[51,52], it thus explains the constitutive secretion of oste-
opontin in several biological fluids (blood, semen, serum,
bile) and its distribution in a very broad variety of tissues
[53]. Our results suggest that the absence of the SP1 DNA
binding site would impair or reduce the transcription
activity of the SPP1 promoter. Unless validation of the
SPP1 transcript or osteopontin protein from cows har-
bouring allele C or T SPP1c.-1251C>T is performed (hap-
lotypes H2 and H5 contained an abolished SP1 binding
site [Table 6]) the veracity of the tangible impact of
SPP1c.-1251C>T on bacterial infection remains unknown.
Further study by in vitro assay using reporter genes and
binding shift assays could help elucidate the impact of
promoter variants on transcription activity.
Table 6: Estimated haplotype frequencies and effects of haplotypes in the bovine SPP1 gene on EBVs for SCSa and for production 
traits.
Genotype Least squares mean
Allele 1 Allele 2 Frequency
(%)
SCS SCS1 SCS2 SCS3 Milk yield 
(Kg)
Fat yield 
(Kg)
Protein 
yield (Kg)
Fat % Protein %
H4 (GCGC) H4 (GCGC) 2 (0.4) 2.81 2.9 2.74 2.79 -594 0 -17 0.22 0.02
H1 (GCGA) H4 (GCGC) 30 (5.2) 2.87 2.90 2.85 2.88 -238 -6 -3 0.03 0.04
H2 (GTAC) H4 (GCGC) 13 (2.2) 2.88 2.88 2.92 2.88 -333 -8 -8 0.04 0.03
H1 (GCGA) H2 (GTAC) 170 (29.4) 2.94 2.96 2.92 2.94 -128 1 -0.7 0.07 0.04
H3 (ACGA) H4 (GCGC) 5 (0.9) 3.01 3.04 3.03 2.96 296 25 8 0.15 -0.01
H1 (GCGA) H1 (GCGA) 205 (35.6) 3.02 3.00 3.01 3.05 42 -2 1 -0.02 0.001
H2 (GTAC) H2 (GTAC) 37 (6.4) 3.02 3.02 3.00 3.01 -99 -13 -2 -0.09 0.02
H4 (GCGC) H5 (GTAA) 6 (1.0) 3.03 3.01 3.03 3.05 -244 4 -8 0.14 0.005
H1 (GCGA) H3 (ACGA) 76 (13.2) 3.16 3.09 3.13 3.17 -139 2 0.1 0.07 0.05
H2 (GTAC) H3 (ACGA) 28 (4.8) 3.17 3.15 3.18 3.2 -198 -7 -2 0.01 0.04
H3 (ACGA) H3 (ACGA) 6 (1.0) 3.38 3.25 3.39 3.50 -517 -11 -10 0.08 0.07
± SEM ± 0.24 ± 0.22 ± 0.26 ± 0.28 ± 567 ± 19 16 ± 0.21 ± 0.08
P value <.001 0.012 <.001 <.001 0.236 0.044 0.745 0.043 0.078
a EBVs are calculated for the respective lactation: over all (SCS), first (SCS1), second (SCS2), and third (SCS3) lactations
Table 7: Estimated haplotype effects on EBVs for SCS.
Average haplotype substitution effect (in EBV units of score)a
Haplotypes SCS SCS1 SCS2 SCS3
Estimated haplotype effect ± SE (P value)
H1 (GCGA) 0.118 ± 0.268 (0.660) 0.034 ± 0.261 (0.896) 0.120 ± 0.295 (0.685) 0.173 ± 0.333 (0.604)
H2 (GTAC) 0.132 ± 0.274 (0.629) 0.061 ± 0.266 (0.818) 0.136 ± 0.300 (0.650) 0.174 ± 0.340 (0.609)
H3 (ACGA) 0.169 ± 0.277 (0.541) 0.071 ± 0.270 (0.793) 0.177 ± 0.305 (0.562) 0.209 ± 0.345 (0.545)
H4 (GCGC) 0.023 ± 0.276 (0.935) 0.030 ± 0.269 (0.913) 0.025 ± 0.303 (0.933) 0.071 ± 0.343 (0.836)
H5 (GTAA) 0.212 ± 0.352 (0.547) 0.090 ± 0.339 (0.790) 0.247 ± 0.382 (0.518) 0.285 ± 0.433 (0.512)
a EBVs are calculated for the respective lactation: over all (SCS), first (SCS1), second (SCS2), and third (SCS3) lactationsBMC Genomics 2009, 10:444 http://www.biomedcentral.com/1471-2164/10/444
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Lastly, two other binding sites, the nuclear factor of acti-
vated T cells (NF-AT) and the interferon-stimulated
response element (ISRE), were positioned close to SPP1c.-
430G>A (-7 and +2 nt, respectively), located in the first
intron. The NF-AT promotes cell proliferation and the
expression of inflammatory cytokines, such as IL-6 and
SPP1 [54], whereas ISRE would regulate the expression of
SPP1 [55]. A polymorphism in this region could poten-
tially affect the binding of these two TFs and influence the
rapidity of the response of SPP1 to infection. Therefore,
functional studies are required to interrogate the signifi-
cance of this SNP with TF binding and gene expression.
In an association study, neither SPP1c.-1251C>T  nor
SPP1c.-430G>A  was found to be associated with SCS
(Table 2). We found that these two are linked (i.e. C/G or
T/A on the same allele; data not shown), which could
explain why only heterozygous animals (CT genotype for
SPP1c.-1251C>T and GA genotype for SPP1c.-430G>A),
when compared to their respective homozygotes, had an
impact on SCS. This was also shown by their opposite
allelic substitution effects (Table 3). Therefore, both allele
C for SPP1c.-1251C>T and allele A for SPP1c. 430G>A,
which are linked to G and T, respectively, would be
required to compensate for the negative effect of the sec-
ond allele.
As innate immunity is not an adaptive immune response,
an association study regarding the genetics should not be
modulated as time passes. In other words, immune
response should be maintained, irrespective of the
number of times the pathogen is encountered. Indeed,
this constant trend (for statistically significant values) was
observed regarding the allele substitution effect (Table 3),
which means that cows harbouring the favourable allele
do not benefit (i.e. there is no decrease of the SCS value)
in later parities from these SPP1c.-1251C>T and SPP1c.-
430G>A SNPs. The SNP SPP1c.-1301G>A was only found
to be associated with SCS in the regression model (Table
2). However, it may also have an impact that was not
revealed by the allele substitution effect. Because of the
discrepancy in the abundance of both alleles (89.5% ver-
sus 10.5%; Table 3), the substitution effect may not be sta-
tistically significant.
For the fourth SPP1c.*40A>C SNP, it is less clear how the
3' UTR DNA polymorphisms affect SPP1, although a more
general mechanism such as microRNA would affect tran-
script stability. We cannot exclude that SPP1 would be rel-
atively more stable than other transcripts in milk cells.
Although amplitude of the SPP1 induction was smaller
than TNF transcript, both were correlated as the bacterial
challenge of the PBMC progressed (data not shown). The
TNF-α is an important inflammatory mediator involved
in neutrophil recruitment [56,57] and SPP1 might acti-
vate or maintained the Th1-Th2 balance. Thus SPP1 could
be either an upregulated gene or stabilized transcript.
MicroRNA are an important class of regulatory RNA that
repress animal genes by preferentially interacting with
complementary sequence motifs in the 3' UTR of target
mRNA [58]. The importance of the region is further high-
lighted by the presence of the SPP1c.*40A>C SNP within
two other bovine species. The presence of this DNA poly-
morphisms was detected within the Guernsey (n = 42)
and Jerseys (n = 81) cows (data not shown). Whereas both
human and mouse 3' UTR of SPP1 are the target of several
microRNA, retrieved by an in silico search (http://
www.microrna.org/; data not shown), this hypothesis
remains to be verified for the bovine SPP1  3' UTR
sequences.
In previous studies, nine DNA polymorphisms were
found within eight sires sequenced for the SPP1  gene.
Whereas one SNP was associated with production traits
(fat and protein yield and percentage, milk yield), this
"OPN3909" was not found associated with SCS [43]. The
main reason may be inherent to the selection of the Hol-
stein dairy cattle population, which in our study was
based on extreme EBV for SCS from a directory of 6,453
bulls (Canadian Dairy Network database). How SPP1
may affect fat yield and fat percentage in bovine milk
remains an open question. In humans, a significant posi-
tive correlation was found between osteopontin levels
and body fat as well as circulating concentrations of total
cholesterol [59]. Osteopontin is also associated with cho-
lesterol gallstone formation in human and mouse [60].
The specific role of osteopontin beyond its immune role
in milk warrants further investigation. From a genetic per-
spective, it is well known that health and disease may
affect other performance traits such as longevity and fertil-
ity among others. Therefore, genetic factors affecting
health trait may impact other traits. For bull fertility, the
EBV for the male fertility index is reported as the non-
return rate trait (Canadian Dairy Network database).
Among the genotyped bulls, we did not find significant
statistical association of the four SPP1 SNP with the EBV
of the non-return rate (data not shown). Even though
osteopontin was reported to influence bull fertility
[61,62], these SPP1 variants were not found associated
with male fertility (data not shown). We cannot exclude
that a genetic association could be observed using bulls
with extreme EBV for the male fertility index. Therefore,
further investigations are still required before suggesting
favourable allele for the innate immune system, such as
how the genetic SPP1 variants may influence male fertility
or milk composition (e.g. concentration of cholesterol).
In fact, milk is used for human consumption and an
increase of the concentration of cholesterol may not be
valuable.BMC Genomics 2009, 10:444 http://www.biomedcentral.com/1471-2164/10/444
Page 10 of 17
(page number not for citation purposes)
In the present study, we found a strong correlation
between SPP1 and SCS, and we identified potential func-
tional sites in the promoter of the gene. The different pro-
moter haplotypes have been cloned, and the relevance of
the functional sites will be studied in order to elucidate
the molecular mechanisms responsible for the abundance
of milk somatic cells in the Holstein dairy population as
well as to depict the immune response to environmental
stimuli.
Conclusion
This study reports the link between DNA polymorphisms
within the innate immune SPP1 gene, the number of milk
immune cells and, potentially, susceptibility to mastitis.
Indeed, one SNP abolished the SP1 recognition site,
whereas another SNP affected the transcription binding
factor IKAROS. These SNPs, located in the promoter, are
potentially involved in the Th1 immune response and in
the Th2 regulation pathway since they were identified by
Nucleotide sequence of the 5' upstream region (GenBank accession No. AY878328) of the bovine osteopontin gene SPP1 Figure 2
Nucleotide sequence of the 5' upstream region (GenBank accession No. AY878328) of the bovine osteopontin 
gene SPP1. The 5' region is indicated in uppercase letters, and position +1 (translation initiation codon) is indicated in italic 
uppercase letters until position *1 (translation termination codon). SNPs are in bold. Putative binding sites (found with http://
motif.genome.jp) are shown in grey or underlined when co-localized: octamer factor 1 = Oct-1; TCF11/KCR-F1/Nrf1 
homodimers = TCF11; LyF-1 = Lyf-1; c-Myb = c-Myb; stimulating protein 1 = SP1; stress-response element = STRE; AP-1 bind-
ing site = AP-1; activator protein 4 = AP-4; IKAROS family zinc finger 1 (Ikaros) = IKZF1; IKAROS family zinc finger 2 (Helios) 
= IKZF2; nuclear factor of activated T-cells = NF-AT; CRE-binding protein 1/c-Jun heterodimer = CRE-BP; signal transducers 
and activators of transcription = STATx; C/EBPalpha CCAAT/enhancer binding protein alpha = CCAAT; GATA-binding factor 
1 = GATA-1; GATA-binding factor 2 = GATA-2; GATA-binding factor 3 = GATA-3; interferon-stimulated response element = 
ISRE; activating transcription factor = ATF.
TTCATGGGCCCTCTAGATGCCCTTCCAGGATGCTGGAAGTCAGTGCTATGAACAAAAAAAGATAGTTAGTGATATTGTACATA
AGTAATGTTTTAACTTTAACTAGCAGGGTAGTGGGTGTTTGTGTGCGTGTGCGCGTGTGTGTGTGCCTGTGTTTGTTCTGTGA
                c-Myb 
CCACAAAACCAGAGGGGGAAGTGTGGGAACAAGTGGGCTGGGTAGTGGCAAAATGCCCCATGACACATCTCTCCGCCCCCTGT
IKZF2         SP1 SP1   STRE
                    SPP1c.-1301G>A                                  SPP1c.-1251C>T
GTAGGTGGAGAGCATCTGGAGCAGCCTTTAAATTCTGGGAGATCCTGGTTGTCAGCAGCAGGGAGAGCAGGCCAGGAGGGCAG
                                   Lyf-1                AP-4 
CACTGAGCACTGCATCAGCATCACAGGGGACTGGACTCTTCTCGCCGCCGCAGACCAAGGTAAGCCTGCAGTTTGCTACAGAC
TCCTGTCCTCTCTGTGCGCTGCCTCATTTCATTGGGAAGGTCAATTTGTAAGGAAAAGAGTATAATGGTAAACACTGTTAATC
                    AP-1        IKZF1/2 
AGACTTGAGTTGTTCTTGTCTTTTGAATATGCATGCCAGATCCAGGGCTGATGTCCTGCAGGAAAGGTGGCCGGTTATTTTGA
                           Oct-1 
AAGACAGTCGAATATAAAACTTGAAAATATTTCCATGGAGTCCTCAAAAGAATTGAGACTACTTTTTTCAGTCAGGAAATAAA
AGAAAAATTCTATGCCCTTTTGGGATGATTGTATATACATCATTTTAATGAATAGATGACCATGGGATATTTAAAAGGAAAAT
                      IKZF2                      TCF11                     NF-AT 
GCTTTTTAGTATTCATATAACCTGACGTTAATGCTAATTTTTAGTGATTTGATTTATCCCTTTTTCAAGGAAAAAAAAAAAAA
                   ATF CRE-BP                                    STATx 
CCCTTTCTGAATATTTTCACCTCTGTATTTAGCTATTAAAATTTCACCCAAATATCTATATGATACTGTTTAGACTTACAAAT
AGAAAAGCTGTTGACTTCAGTGTTTTCTTTTTCATTTCAAACTTTTAGAATACCTTGACTTACTAACCTTAGAGACAGCTACA
TTACACCTAACTAATACCTTTTAAATAATTTAAAATCACATTTGAAATGCATGTTGGAAAATGGAGACAGCAAGTTTCTCTTT
NF-AT SPP1c.-430G>A   ISRE
CTTATTTTTATCTTCTCTCTTCATGTTTTTCTTCTCTGAAAAGTAAATATTCTCATTCTTGCTTTATTATTTTAATTCAATTA
CTGCTGATCTGTTTTTAGGTTTAGATAGCTGGAGATATCAGGTAGTAATGGTGTAATCTCTGAAACTCTAAATGTTAAAGTCG
AATAAATATAGATTTGTAAAATTCCTCTCTCCCTTGCCTAATAGTGAGAGATGGAAAATAGAGGTGGCAGTACAAATATTAAC
TCAAAAGATCATAATATTAAAAAGAAATTAGTGGAGTGTTTCCACACAAAATACATATTTATTTGTGATGATTTTGTAATGTG
     GATA-3                                                              CCAAT
GTAGCCTAAAAAAAGTATCACTGTTTTGACCTTAGAAAAGATAAAATATTTCTTACAAAATATTTTGCAGGAAAAATCATTAC
                                    GATA-1/2/3                   STATx  NF-AT 
CATGAGAATTGCAGTGATTT …… GGTCAATTGAAAGGAGAAAATACAATTTCTTACTTTGCTTTTAGTAAAAAGAAAAGGA
 +1                             *1 SPP1c.*40A>CBMC Genomics 2009, 10:444 http://www.biomedcentral.com/1471-2164/10/444
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in silico search to abolish these transcription factor recog-
nition sites. Because these SNPs are associated with the
level of immune (somatic) cells measured in milk which
is associated with clinical mastitis and because of their
potential implication in the Th1- Th2, all together, these
findings suggest the genetic potential of these variants in
terms of selection for improving mastitis resistance in
dairy cows. But osteopontin is not only involved in regu-
latory mechanisms of the immune response but also in
mammary gland development and milk secretion. Thus,
before recommending any SPP1  haplotype for genetic
selection, the beneficial role of these genetic forms would
require further investigation.
Methods
Animals
Twenty multiparous Holstein cows were selected from
surrounding dairy farms based on several criteria. All cows
were from different dam and sire families, and had low
SCC ranging from 5 × 104 to 1 × 105 cells/mL, no past his-
tory of mastitis, tested negative for bovine virus diarrhoea,
leucosis, neospora and mycoplasmosis, and were found
to be free from bacteria in aseptically collected milk sam-
ples. Milk was aseptically sampled from each quarter
every week starting at calving until the end of the trial
period (110 to 170 days of lactation). Four cows were kept
for the study based on these criteria: no calving associated
problem and bacteriologically negative milk samples with
SCC values below 1 × 105 cells/mL across lactation. The
cows were transferred to the level 2 biosecurity facility one
week before the challenge. They were handled according
to the Guide for the Care and Use of Agricultural Animals
by the Institutional Animal Care and Use Committee at
Agriculture and Agri-Food Canada's Dairy and Swine
Research and Development Centre (Document 188).
Bacteria and intramammary challenge
Escherichia coli strain SHY97-3923-2, previously isolated
from a clinical case of bovine mastitis and kindly pro-
vided by the Laboratoire provincial de pathologie animale
(St-Hyacinthe, Quebec, Canada), was used for the
intramammary challenge. An antibiotic susceptibility test
was validated on the strain (Biovet, St-Hyacinthe, Quebec,
Canada). The bacteria were cultivated in tryptic soy broth
(TSB) and the fresh starter was incubated for approxi-
mately 3 h to bring it to an exponential growth phase (0.6
to 0.7 OD). The culture was then centrifuged, washed
once in pyrogen-free saline (PFS) and re-suspended fol-
lowing an established serial dilution protocol to get a final
concentration of 1,000 CFU/mL. The concentration was
confirmed by plating 200 μL of three independent dilu-
tions on TSA. The 3-mL volume was injected in the chal-
lenged glands via the teat canal immediately after the
morning milking in the left and right rear quarters of the
mammary gland (n = 4 cows). As controls, the right and
left front quarters of each cow were infused with 3 mL of
sterile saline solution. All the quarters were then massaged
to ensure dispersal of the inoculum. Bacteriological anal-
ysis was conducted by plating 200 μL of each milk sample
from each quarter onto TSA overnight at 37°C to deter-
mine the number of colony-forming units over the chal-
lenge.
Clinical signs, collected samples and assays
Antibiotic treatment (Borgal; Hoechst, Montreal, Canada)
and pain relief medicine (Anafen; Merial, Baie d'Urfé,
Canada) were administered following 6 h (n = 2 cows)
and 12 h (n = 2) according to the Guide for the Care and
Use of Agricultural Animals. Rectal temperature and gen-
eral state were monitored for each cow every 3 h. The SCC
in milk samples were analyzed by the Dairy Production
Centre of Expertise (Valacta, Montreal, Quebec, Canada)
and provided values on crude milk. All contaminated
samples were processed in the level 2 biosecurity microbi-
ology laboratory. The tumour necrosis factor-alpha (TNF-
α) concentration in the milk samples was determined
using an enzyme-linked immunosorbent assay (ELISA)
kit provided by the Vaccine and Infectious Disease Organ-
ization (Saskatoon, Saskatchewan, Canada). The assay
was performed according to the protocol developed at the
Vaccine and Infectious Disease Organization and as
described previously by other authors [63].
Fluorescence-activated cell sorting
Measurement of differential leukocyte populations in
milk was performed by flow cytometry using the SYTO 13
labelling method, as described previously by other
authors [64] but with some modifications. Briefly, 15 mL
of collected milk was added to 35 mL of 1× Hank's bal-
anced salt solution without Ca2+ or Mg2+ (HBSS 10×; Inv-
itrogen, Toronto, Ontario, Canada) and centrifuged. The
pellet was re-suspended in RPMI-1640 (Invitrogen) sup-
plemented with 5% fetal bovine serum (FBS; Invitrogen)
at 1 × 105 to 1 × 106 cells/mL. Then, 490 μL was transferred
to a new tube, and 10 μL of diluted SYTO 13 green fluo-
rescent nucleic acid stain solution (1:400 in RPMI-1640; 5
mM, Invitrogen) was added. After 10 min in the dark, the
staining was stopped with 4 mL of HBSS 1×, and the cells
were recolted. The pellet was re-suspended in 400 μL of
cold RPMI-1640 supplemented with 5% FBS, and was
analyzed with a Coulter Epics XL-MCL flow cytometer
using Expo 32 software (Beckman Coulter, Mississauga,
Ontario, Canada). The forward scatter and side scatter
were measured on a linear scale, whereas green fluores-
cence was registered on a log scale. The differential leuko-
cyte count in milk after SYTO 13 staining was quantified
using the side scatter/green fluorescence dot plot. The per-
centage of different leukocyte populations in milk sam-BMC Genomics 2009, 10:444 http://www.biomedcentral.com/1471-2164/10/444
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ples was established, after counting 10,000 events, as
follows: percentage of the number of cells in the gated leu-
kocyte population out of the total number of gated lym-
phocytes, macrophages and granulocytes.
RNA extraction and analysis
Mammary quarters were sampled aseptically. Twenty mL
was diluted in an equal volume of PBS and centrifuged at
180 × g for 10 min at 4°C. The cell pellet was washed with
cold PBS and 1 mL of TRIzol (Invitrogen, Carlsbad, Cali-
fornia, USA) was added. The RNA extraction was per-
formed as recommended by the manufacturer but with
minor modifications. The RNA samples were resuspended
in water with SUPERase. In (1 U/μL; Ambion) and treated
with Recombinant DNase I (Ambion). The final concen-
tration was determined using a NanoDrop ND-1000 spec-
trophotometer. For each cow, equal amounts of RNA
from the infected rear quarters and the non-infected fore-
quarters were pooled, with one pool for the infected quar-
ters and one for the non-infected quarters. RNA was
amplified using the SMART mRNA Amplification Kit
(Clontech, Mountain View, California, USA) according to
the manufacturer's protocol. This kit uses the template-
switch mechanism to generate the double-stranded cDNA
necessary for in vitro transcription without the polymerase
chain reaction (PCR) step that is generally associated with
a conventional SMART technique. The cDNA library was
performed according to the recommended protocol for
the PCR-Select cDNA Subtraction Kit (Clontech), which is
a suppressive subtractive hybridization (SSH) technique.
Briefly, equal amounts of amplified RNA from both
infected quarters of cows were pooled prior to the hybrid-
izations. The same pooling step was performed for the
non-infected quarters. The pool of infected samples was
used as the "tester" in accordance with the SSH procedures
and was subtracted with an excess of the "driver," the
"driver" being the pool prepared from transcripts derived
from the non-infected quarters. Consequently, this
scheme allows the generation of a differential representa-
tion of infected transcripts normalized with non-infected
transcripts. Supplementary PCR amplifications of the
hybridization product were then cloned into a TA vector
(pCRII, Invitrogen) and transformed into MAX Efficiency
DH5α-competent cells (Invitrogen) to make up a cDNA
library. To identify clones containing a single insert, each
clone was submitted to PCR using NP1 and NP2R prim-
ers, and the products were electrophoresed on a 2% agar-
ose gel. Clones were sequenced according to the BigDye
Terminator v3.1 Cycle Sequencing Kit protocol with a
3100-Avant genetic analyzer (Applied Biosystems, Foster
City, California, USA). Lastly, gene similarity was
searched among our sequences using the Basic Local
Alignment Search Tool (BLAST) algorithm of the National
Center for Biotechnology Information (NCBI) public
database.
Isolation of bovine PBMC and induction
Peripheral blood mononuclear cells (PBMC) were iso-
lated from the buffy coat fractions of peripheral blood and
further purified by Ficoll and sucrose gradients. Blood was
collected from the jugular or caudal vein in 10 × heparin
(1:10) tubes (n = 3 cows). Centrifugation was performed
at 572 × g for 15 min at 18°C. For the respective cow, the
fractions were pooled together, completed to 40 mL with
1× HBSS (Hanks' Balanced Salt Solution without Ca2+ and
Mg2+; Wisent, St-Bruno, Canada), poured very slowly
onto 2 × Ficoll gradients (Ficoll Paque Plus; Amersham,
Baie d'Urfe, Canada), and centrifuged at 572 × g for 40
min at 18°C. The PBMC were rinsed with 1× HBSS, re-sus-
pended in 5 mL of 1× HBSS and poured onto a 20%
sucrose (Sigma, Oakville, Ontario) discontinous gradient
prior to centrifugation at the same parameters described
above. The PBMC were rinsed with 1× HBSS and the cell
pellets were treated with Red Cell Lysis buffer (Sigma) to
eliminate residual erythrocytes. Finally, PBMC were re-
suspended in 2 mL RPMI-1640 (Wisent) with 5% foetal
calf serum (Wisent). Cells were cultured at 5 x 106 in 12
wells flat bottom plate at 39°C in 5% CO2 in a humidified
atmosphere. Cells were incubated for 45 min to allow
monocytes to attach before bacterial induction and incu-
bated with either medium alone (nonstimulated) or with
heat-inactivated bacteria (63°C for 30 min, as described
before [65]) at a concentration of 30 CFU/PBMC. The
samples were harvested immediately after the attachment
period (time zero) or after 0.5, 1, 3 or 5 h post-infection.
Cells in suspension were harvested, 1 mL of TRIzol was
added to each well and transferred to the respective pellet
cells in order to recover both attached and cells in suspen-
sion. The RNA extraction was performed as described
above.
RT-PCR and quantitative RT-PCR
The reverse transcription (RT) was performed with 1 μg of
RNA according to the SuperScript II RT procedure (Invit-
rogen). Each RT assay was made in a 20-μl reaction using
Oligo(dT)12-18 (Invitrogen) as a primer and according to
the supplier's recommendations. Quantitative RT-PCR
(qRT-PCR) was performed in a 10-μL final volume using
5 μL of Fast SYBR Green Master Mix 2× (Applied Biosys-
tems), 300 nM of both forward and reverse primers (Addi-
tional file 3), and 2 μL of diluted template. All RT
reactions were performed in triplicate. The amplification
was carried in a 7500 Fast Real-Time PCR System (Applied
Biosystems) following denaturation of 20 s at 95°C and
amplification during 40 cycles of denaturation at 95°C for
3 s followed by an annealing/elongation period of 20 s at
60°C. Three reference genes were also measured, namely
actin beta (ACTB), glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) and peptidylprolyl isomerase A (PPIA).
The qRT-PCR results were analyzed according to the rela-
tive quantification method given by the arithmetic for-
mula 2-ΔΔCt [66].BMC Genomics 2009, 10:444 http://www.biomedcentral.com/1471-2164/10/444
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Genetic DNA material and EBVs for the SCS and milk 
production traits
Selection of Holstein genetics was performed using infor-
mation downloaded from the Canadian Dairy Network
database (Guelph, Ontario, Canada), which can also be
accessed using the web interface http://www.cdn.ca/. The
EBV data for the August 2008 genetic evaluation were
downloaded onto a local server. These EBVs comprised
the SCS, the non-return rate, and production (protein and
fat yields, protein and fat percentages, and milk yield)
over lactations. The semen of 578 bulls presenting a mean
EBV of 3.01 (Table 8) for the SCS, which is very close to
the breed average (3.00; Canadian Dairy Network data-
base), was available for the study. Table 8 describes the
EBVs (SCS) for the different lactations. Among the 6,453
recorded bulls, two selections were made using the 150
lowest-ranked and 150 highest-ranked bulls for the EBV
for SCS. Among these two groups, semen was available for
51 and 50 bulls, corresponding respectively to the low
and high cohorts for the EBV (SCS), and thus defined as
the low SCS (2.48 ± 0.07) and the high SCS (3.72 ± 0.17)
pools. Genomic DNA (gDNA) was extracted from semen
samples, as described previously by other authors [67]
and concentration was measured using the NanoDrop
ND-1000 spectrophotometer.
SNP mining and sequencing
A sequence of 12,300 bp (GenBank accession No.
AY878328) was retrieved by a BLAST search for similarity
to a consensus sequence assembled from the SPP1 tran-
script sequences from our cDNA library. We used the mul-
tiple sequence alignment methods (CLUSTALW) of the
DNASTAR suite program MegAlign (Lasergene, v7.2;
DNASTAR, Madison, Wisconsin, USA) (data not shown).
The sequence of the 5' region of SPP1 was analyzed in sil-
ico for identification of transcription factors' recognized
DNA binding motifs (Figure 2) using the software MOTIF
Search http://motif.genome.jp/ with a cut off score of 85.
To construct both pools (high and low EBV for SC) for
SNP detection, equal amount of each bulls was PCR-
amplified for the respective delimited genomic sequence
of SPP1 (promoter or respective exons) using the appro-
priate primers designed from the AY878328 sequence
(Additional file 4). PCR reactions were carried out in a
final volume of 50 μL containing 2 ng of template, 200
nM of each primer, 200 μM of each dNTP, 1.5 mM of
MgCl2, 1× PCR buffer (20 mM of Tris-HCl pH 8.4, 20 mM
of KCl) and 1 U of Taq DNA polymerase (BioShop Can-
ada, Burlington, Ontario, Canada). The conditions were
94°C for 3 min, followed by 35 cycles of 30 s of denatur-
ation (94°C), 30 s of annealing (59°C) and 1 min of
elongation (72°C), followed by 5 min of final elongation
(72°C). The amplicon size was confirmed by 1.2% agar-
ose gel electrophoresis. The amplified fragments were
purified using NucleoFast PCR plates (Macherey-Nagel
distributed by MJS BioLynx, Brockville, Ontario, Canada),
quantified with the NanoDrop and diluted to a final con-
centration of 10 ng/μL. To construct the selective DNA
pools, equal amounts of the amplified genomic fragments
from each bull were assembled into the respective high
and low EBV (SCS) pools. Two pools comprising different
individuals were assembled, one each for the high and
low EBV (SCS) DNA. These pools were used as templates
for sequencing with the BigDye Terminator v3.1 Cycle
Sequencing Kit (Applied Biosystems) according to the
company's recommendations, using the forward or
reverse PCR primer (Additional file 4) to sequence both
strands. When a SNP was detected (overlap of nucleotide
bases), all bulls from the pool were individually
sequenced to confirm the DNA polymorphisms.
SNP genotyping
Five hundred seventy-eight bulls, from 26 different sires,
were genotyped using tetra-primer amplification refrac-
tory mutation system PCR (ARMS-PCR), as described pre-
viously by other authors [68-70]. Primers designed using
the open source Cedar Genetics Software http://
cedar.genetics.soton.ac.uk/public_html/primer1.html are
listed in Additional file 5. Reactions were carried out in a
25-μL final volume containing 50 ng of template in the
presence of the appropriate concentration of primers
(Additional file 5), 200 μM of each dNTP, 1.5 mM of
MgCl2, 1× PCR buffer (20 mM of Tris-HCl pH8.4 and 20
mM of KCl), and 1 U of Taq DNA polymerase (BioShop
Canada). The PCR reactions were performed at 94°C for
3 min, followed by 35 cycles of 30 s of denaturation
(94°C), 30 s of annealing at the appropriate temperature
(Additional file 5) and 1 min of elongation (72°C), fol-
lowed by 5 min of final elongation (72°C). The genotypes
were determined according to the fragment length ana-
lyzed following 2% agarose gel electrophoresis, as
described previously by other authors [68].
Statistical analysis
Descriptive statistics for the selective pools (high and low
EBV pools for SCS) and the genotyped cohort of 578 bulls
are presented in Table 2. Allele and genotype association
analyses were done through comparison of the frequen-
cies of the different genotypes and alleles with EBVs for
SCS for the respective lactation using logistic regression.
Conformance of the allele frequencies with the Hardy-
Weinberg equilibrium for all the SNPs was tested using
the Chi-square test. All analyses were performed using Sta-
tistical Analysis System (SAS) software (release 9.1; SAS
Institute, Cary, North Carolina, USA).
The average allele substitution effects of the SNPs were
calculated using the model described above [68], as fol-
lows:BMC Genomics 2009, 10:444 http://www.biomedcentral.com/1471-2164/10/444
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where Yjk is the trait EBV of the jth animal in the kth sire, μ
is the overall mean, βi is the fixed linear regression coeffi-
cient for the ith SNP, Gi is the genotype of the ith SNP
recoded [71] (namely -1 [homozygous dominant/abun-
dant genotype], 0 [heterozygous genotype] or 1
[homozygous recessive genotype]), Sj is the random poly-
genic effect of the jth (1 to 26) sire, and ejk is the random
error. The bull's EBVs for SCS in the first (SCS1), second
(SCS2), third (SCS3) and global (SCS) lactations were
used.
Haplotype
The four SNPs detected in the osteopontin gene were used
for the construction of haplotype blocks. A total of 578
bulls distributed into 26 Holstein families were selected,
thus eliminating families with fewer than 10 offspring.
The haplotype reconstruction was performed using the
HAPROB algorithm [72], and the results were compared
using Haploview (v4.1; [73]). Each family comprised a
minimum of 10 half-sib sons, which is considered a min-
imum family size for reaching greater than 80% accuracy,
as reported previously by other authors [72]. From the
578 bulls genotyped, 16 haplotypes were reconstructed,
but 11 of those had very low probabilities and were then
pooled together to represent a single haplotype for the
study on haplotype effect. The linear effects of the six hap-
lotypes were estimated, restricting block H6 to an esti-
mated effect equal to 0 to account for a linear dependency
among haplotype effects, as described elsewhere [68].
Haplotype effects were estimated with PROC MIXED of
SAS (SAS Institute), using the same model as described
above [68], as follows:
where Yjk is the trait EBV of the jth animal in the kth sire, μ
is the overall mean, βi is the fixed linear regression coeffi-
cient for the ith haplotype, Hapik is the probability of the
ith haplotype for the kth bull, Sj is the random polygenic
effect of the jth (1 to 26) sire, and eijk is the random error.
Results were considered significant if P values were less
than 0.05.
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Table 8: Descriptive statistics of the EBVs for the SCS trait for the Holstein bullsa.
EBVb units Bulls selected for SNP mining
Bulls' cohort Low EBV for SCS High EBV for SCS
Nb Mean ± SD [min-max] Nb Mean ± SD [min-max] Nb mean ± SD [min-max]
SCS 578 3.01 ± 0.35 [2.34-4.16] 51 2.48 ± 0.07 [2.34-2.72] 50 3.72 ± 0.17 [2.99-4.16]
SCS1 521 3.00 ± 0.31 [2.36-4.36] 49 2.53 ± 0.08 [2.36-2.65] 45 3.63 ± 0.18 [3.37-4.36]
SCS2 521 3.00 ± 0.37 [2.28-4.12] 49 2.47 ± 0.09 [2.29-2.62] 45 3.76 ± 0.15 [3.40-4.12]
SCS3 521 3.03 ± 0.41 [2.08-4.15] 49 2.42 ± 0.13 [2.13-2.70] 45 3.82 ± 0.19 [3.42-4.26]
Breed average: 3.00 Selected sub-group average: 3.09
a EBV values from the Canadian Dairy Network database, evaluation published on August 2008
b EBVs are calculated for the respective lactation: over all (SCS), first (SCS1), second (SCS2), and third (SCS3) lactations.BMC Genomics 2009, 10:444 http://www.biomedcentral.com/1471-2164/10/444
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